pharma news today glp-1 2025 GLP1 agonists set to become the best-selling drugs in 2024: GlobalData GLP-1 Agonists Weight Loss Drugs
Description
Jill Carnahan for a powerful, research-informed, and deeply compassionate conversation
Very few include older adults at high risk
Don't want to switch to Wegovy
adults to understand public opinion on GLP-1s.
Gluten-free, keto, unflavored, 30 servings.
Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for the wonder drugs
